Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ospemifene for Moderate to Severe Vaginal Dryness in VVA
NCT02638337Phase 3Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jan 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ospemifene in Vulvovaginal atrophy (VVA), sponsored by Shionogi & Co., Ltd.. Started Jan 2016; status: completed.
02
Drugs
ospemifene
03
Conditions
Vulvovaginal atrophy (VVA)
Beyond the preview
Go deeper on NCT02638337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02638337.